Targacept , Inc. (NASDAQ:TRGT)
| CAPS Rating |
|
|---|---|
| Open | $6.18 |
| Previous Close | $6.21 |
| Daily Range | $6.04 - $6.28 |
| 52-Week Range | $4.91 - $30.47 |
| Market Cap | $202.60M |
| P/E Ratio | 45.90 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 161,950 |
| Average Daily Volume | 0 |
TRGT
VS S&P 500 (SPY)
How do you think TRGT will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
TRGT Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
TRGT News and Commentary
- Tomorrow's Monster Stock – The Motley Fool
- Targacept Sees More AstraZeneca Backing On Alzheimer's Drug – SmartMoney
- The Worst Health Care Stocks of 2011 – The Motley Fool
- 5 of Last Week's Biggest Losers – The Motley Fool
- Last Week's Biggest Stock Laggards – The Motley Fool
- The Market Just Spanked My Stock! – The Motley Fool
- S&P 500's Big Spenders Beat Top Savers in 2011 – The Motley Fool
- UPDATE: AstraZeneca/Targacept Antidepressant Misses Study Goal – SmartMoney
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- This $581 Doughnut Hole Costs Drugmakers – The Motley Fool
- Our Top Biotech Stock Idea – The Motley Fool
- Biotech Pops, Drops, and Break-Ups – The Motley Fool
- AstraZeneca: TC-5214 Well Tolerated, But Didn't Meet Primary Endpoint – SmartMoney
- The 8 Highest Potential Returns in Biotechnology – The Motley Fool
- TRGT Tries Again With Alzheimer's Disease Drug Candidate – The Motley Fool
- The Fastest-Growing Biotech Stocks – The Motley Fool
- May Bottomfest – Blog at The Motley Fool
- Our Top Stock Idea – The Motley Fool
- Targacept's $75M Stock Offering Targets Cognitive Disorders R&D – The Motley Fool
RSS Headlines
Fool UK
